Purple Biotech (PPBT) Interest & Investment Income (2016 - 2025)
Purple Biotech has reported Interest & Investment Income over the past 6 years, most recently at $1.3 million for Q4 2022.
- Quarterly Interest & Investment Income rose 2426.79% to $1.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $910000.0 through Dec 2022, up 384.38% year-over-year, with the annual reading at $424000.0 for FY2025, 51.15% down from the prior year.
- Interest & Investment Income was $1.3 million for Q4 2022 at Purple Biotech, up from -$248000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.3 million in Q4 2022 and troughed at -$248000.0 in Q3 2022.
- The 5-year median for Interest & Investment Income is -$78000.0 (2019), against an average of $24818.2.
- The largest YoY upside for Interest & Investment Income was 2426.79% in 2022 against a maximum downside of 264.71% in 2022.
- A 5-year view of Interest & Investment Income shows it stood at -$69000.0 in 2018, then fell by 13.04% to -$78000.0 in 2019, then tumbled by 117.95% to -$170000.0 in 2020, then surged by 67.06% to -$56000.0 in 2021, then skyrocketed by 2426.79% to $1.3 million in 2022.
- Per Business Quant, the three most recent readings for PPBT's Interest & Investment Income are $1.3 million (Q4 2022), -$248000.0 (Q3 2022), and -$89000.0 (Q2 2022).